The study will focus on unveiling the mechanisms underlying the adaptation of dendritic cells and neutrophils to different tissues and organs and how this changes with ageing.
Read moreCNIO researcher María Casanova-Acebes has been awarded a grant from the European Research Council to discover how to adjust the administration of cancer treatments to the time of day when they prove ...
Read moreLa inmunoterapia tras el tratamiento con ERBITAX mostró una supervivencia notablemente prometedora a pesar del posible sesgo de selección
Read moreTres recientes investigaciones, apuntan al factor plaquetario 4 (PF4), una proteína liberada por las plaquetas al activarse, como elemento de la sangre con efecto antienvejecimiento. Además, tambié...
Read moreIt has been is expected that people with a sleep disorder who have had severe COVID, have a less responsive immune system. In conclusion, the presence of an untreated sleep disorder would condition a ...
Read moreInvestigadores del Cima Universidad de Navarra confirman que las proteínas cIAPs desempeñan un papel crucial en la activación y función de los linfocitos a través del receptor CD137 y promueven s...
Read moreLa sarna o escabiosis es una enfermedad de la piel muy contagiosa producida por el parásito Sarcoptes scabiei hominis, un ácaro microscópico de forma ovalada y plana con ocho patas, con un aparato ...
Read moreInvestigadores de la Universidad de Munich y la Universidad Técnica de Munich están desarrollando una nueva forma de inmunoterapia dirigida a activar al sistema inmunitario frente al cáncer que com...
Read moreCurrently, lymphoma accounts for 4% of all new cancer cases in Spain. It is rare compared to the most common cancers. However, there are many questions surrounding lymphoma and, above all, its treatme...
Read moreIBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal p...
Read moreA study led by the Disease Biomarkers and Molecular Mechanisms Research Group (DIBIOMEC) of the Institut d’Investigació Sanitària Pere Virgili (IISPV) and in collaboration with the Rheumatology Se...
Read more3P Biopharmaceuticals and the Swedish company, Toleranzia AB, have successfully accomplished 1000 L full-scale GMP manufacturing of TOL2 drug substance destinated to be used in clinical study.
Read more